Turn Therapeutics to Host Open Investor Session in Connection with Expected Public Listing on Nasdaq
LOS ANGELES, September 15, 2025--(BUSINESS WIRE)--Turn Therapeutics®, a clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease, today announced it will host a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results